Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages

  Ahmed, Ashraf H ^a   Gordon, Richard D ^a   Taylor, Paul J ^a   Ward, Gregory ^b   Pimenta, Eduardo ^a   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; RENIN;

ADRENAL SUPPRESSION; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; OVULATION; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FALSE POSITIVE REACTIONS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; IMMUNOASSAY; MALE; MENSTRUAL CYCLE; PROGESTERONE; RENIN; SEX CHARACTERISTICS; TANDEM MASS SPECTROMETRY;

EID: 79951707539     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1355     Document Type: Article

References (25)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318 (Pubitemid 24201225)
2. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
3. Young Jr WF 1999 Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 7:207-214
4. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902 (Pubitemid 35434913)
5. Stowasser M, Gordon RD 2004 The aldosterone-renin ratio in screening for primary aldosteronism. Endocrinologist 14:267-276 (Pubitemid 39232121)
6. Fommei E, Ghione S, Ripoli A, Maffei S, Di Cecco P, Iervasi A, Turchi S 2009 The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women. J Hum Hypertens 23:130-135
7. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618 (Pubitemid 46699525)
8. Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, Guidi GC, Franchi M, Corrocher R, Olivieri O 2010 Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens 28:135-142
9. Gordon MS, Chin WW, Shupnik MA 1992 Regulation of angiotensinogen gene expression by estrogen. J Hypertens 10:361-366
10. Fischer M, Baessler A, Schunkert H 2002 Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53:672-677
11. Oelkers WK 1996 Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166-171 (Pubitemid 26146736)
12. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
13. Gordon RD 2004 The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens 22:251-255 (Pubitemid 38250981)
14. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M 2006 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to RIAs with and without extraction steps. Clin Chem 52:1749-1755 (Pubitemid 44330710)
15. Turpeinen U, Hämäläinen E, Stenman UH 2008 Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 862:113-118
16. Taylor PJ, Cooper DP, Gordon RD, Stowasser M 2009 Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem 55:1155-1162
17. Guo T, Taylor RL, Singh RJ, Soldin SJ 2006 Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 372:76-82 (Pubitemid 44286760)
18. Vogeser M, Parhofer KG 2007 Liquid chromatography tandemmass spectrometry (LC-MS/MS)-technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115:559-570 (Pubitemid 350070925)
19. Gray MJ, Strausfeld KS, Watanabe M, Sims EA, Solomon S 1968 Aldosterone secretory rates in the normal menstrual cycle. J Clin Endocrinol Metab 28:1269-1275
20. Katz FH, Romfh P 1972 Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol Metab 34:819-821
21. Szmuilowicz ED, Adler GK, Williams JS, Green DE, Yao TM, Hopkins PN, Seely EW 2006 Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab 91:3981-3987 (Pubitemid 44536873)
22. Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A 2003 Conception and pharmacodynamic profile of drospirenone. Steroids 68:891-905 (Pubitemid 37532413)
23. Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV 2007 The influence of the route of estrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol (Oxf) 66:632-635 (Pubitemid 46699528)
24. Hannemann A, Friedrich N, Lüdemann J, Völzke H, Rettig R, Peters J, Reincke M, Döring A, Nauck M, Wallaschofski H 2010 Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).Horm Metab Res 42:392-399
25. Rossi GP, Pessina AC, Heagerty AM 2008 Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens 26:613-621 (Pubitemid 351354903)